Melanoma other diagnostic studies: Difference between revisions
Created page with "{{CMG}} {{Melanoma}} ==Overview== ==Future techniques== <p>In addition to identifying high-risk patients, researchers also want to identify high-risk lesions within a given ..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{CMG}} | ||
{{Melanoma}} | {{Melanoma}} | ||
| Line 9: | Line 10: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 20:18, 21 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Melanoma other diagnostic studies |
|
Risk calculators and risk factors for Melanoma other diagnostic studies |
Overview
Future techniques
In addition to identifying high-risk patients, researchers also want to identify high-risk lesions within a given patient. Many new technologies, such as optical coherence tomography (OCT), are being developed to accomplish this. OCT allows pathologists to view 3-D reconstructions of the skin and offers more resolution than past techniques could provide. In vivo confocal microscopy and fluorescently tagged antibodies are also proving to be valuable diagnostic tools.